Prophylactic Effect of Trimethoprim-Sulfamethoxazole on Pneumocystis Pneumonia in Lung Cancer Patien

来源 :北京放射肿瘤学术论坛 | 被引量 : 0次 | 上传用户:jff3551
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background and Purpose: Radiation pneumonitis is a common complication of thoracic radiation.Our clinical experience suggested that Pneumocystisjiroveci pneumonia (PCP) contributes significantly to the mortality rate of chemoradiotherapy-induced severe radiation pneumonitis (SRP) in lung cancer patients.We evaluated the efficacy of PCP prophylaxis during the treatment of SRP.Materials and Methods: We retrospectively analyzed 24 lung cancer patients treated with chemoradiotherapy who developed SRP between 2009 and 2011.SRP was defmed as grade ≥3 radiation pneumonitis using the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0.Patients who had received the typical corticosteroid treatment constituted the standard group, and those who had additionally received trimethoprim-sulfamethoxazole comprised the prophylaxis group.PCP incidence and the mortality rates of the 2 groups were compared.Results: The incidence of PCP infection was 43% in the standard group and 0% in the prophylaxis group (p =0.024).After a 3-month post-diagnosis follow-up, 5 of the 24 patients, all from the standard group, died; PCP infection was the cause of death in 3 patients.Conclusions: Trimethoprim-sulfamethoxazole prophylaxis can substantially reduce the incidence of PCP and the mortality rate from SRP in lung cancer patients who develop SRP after treatment with chemoradiotherapy.
其他文献
会议
目的 评价采用螺旋断层放疗技术通过靶区内剂量递增治疗胰腺癌的安全性、放疗毒副反应和有效性. 材料和方法 入组条件:病理学、细胞学诊断为胰腺癌;无法取得病理经临床症状、影像学表现及检验等支持,且因医学原因不能或不愿手术的胰腺癌患者,仰卧坚持30分钟以上.2011-10~2012-10共入组25例,男18例,女7例;中位年龄66岁;Ⅱ期7例,Ⅲ期18例(hJCC分期);胰头颈19例,胰体尾6例.采用热
目的:利用EPID图像实时读取预埋于体内金球的投影位置,并自动重建金球在靶区中的投影位置坐标.方法:利用matlab软件编制EPID图像读取和处理金球投影位置的计算程序并自动重建金球在靶区中的投影位置坐标,该程序基本步骤如下:(a)读取EPID图像,并对其进行剪裁获得相同的合适大小.(b)对图像进行双立方缩小,高斯滤过(平均滤过),拉普拉斯锐化(亮斑滤过),二值化后取反,图像叠加,Canny边缘剪